The Basic Advocacy Training SessionThe training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.
|
The Basic Advocacy Training SessionThe training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.
|
On the Invitational Conference on Drug User Activism Sponsored by the Danish Drug Users Union (BrugerForeningen) and Dutch National Interest Group of Drug Users (Landelijk Steunpunt Druggebruikers 2003, October 31st/November 1st Copenhagen, Denmark Howard S. Lotsof Board of Directors NAMA President, Dora Weiner Foundation http://www.doraweiner.org Submitted 27 November 2003 I came to be informed of…
The bias and misunderstandings about methadone as a medication often result in methadone patients being refused medical care (Umbricht-Schneiter, 1994; Zweben and Sorensen, 1988). Another common scenario is that their medication is used to coerce or manipulate methadone patients into medical treatment (Blansfield, 1992). In other areas of medicine such actions would be considered unethical…
James P. Connolly, CMA PA-NAMA and NAMA Newtown, PA Rebecca Ballard, CMA OK NAMA Tulsa, OK Carolyn Miranda, CMA NAMA SOCAL Fountain Valley, CA Changes in the service environment of MAT, expecially accreditation, are affecting relationships of patients, providers, and outside agencies. A panel of NAMA advocates will describe experiences with patient committees, staff advocacy…
T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…
National Alliance of Methadone Advocates June 14, 2004 Contact: Joycelyn Sue Woods, M.A., C.M.A., President Phone/Fax (212) 595-NAMA/6262 Walter Ginter, C.M.A., Vice President Phone (203) 233-8266 In a few days the first proposals requesting funds from President Bush’s One Hundred Million Dollar Access to Recovery Program are due in Washington. The purpose of these grants…
20th Anniversary National Methadone Conference American Association for the Treatment of Opioid Dependence October 16-20, 2004 – Orlando, Florida Saturday: October 16, 2004 Preconference Events The Certified Methadone Advocate Course Sunday: October 17, 2004 Special Meeting Patient Support Community and Education Project Meeting Monday: October 18, 2004 NAMA Organizational Meeting Wednesday: October 20, 2004 Workshop…